OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
Mingxi Li, Yifei Ren, Zhen Qin Aw, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants
Bin Ju, Qi Zhang, Ziyi Wang, et al.
Nature Immunology (2023) Vol. 24, Iss. 4, pp. 690-699
Open Access | Times Cited: 34

Biospecific Chemistry for Covalent Linking of Biomacromolecules
Li Cao, Lei Wang
Chemical Reviews (2024) Vol. 124, Iss. 13, pp. 8516-8549
Open Access | Times Cited: 11

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang Yang, Fang Li, Lanying Du
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9

S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines
Yong‐Sik Bong, David Alan Brown, Ezra Chung, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1

Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants
Bingchen Yu, Shanshan Li, Takako Tabata, et al.
Chem (2022) Vol. 8, Iss. 10, pp. 2766-2783
Open Access | Times Cited: 35

Who Is the Intermediate Host of RNA Viruses? A Study Focusing on SARS-CoV-2 and Poliovirus
Carlo Brogna, Domenico Rocco Bisaccia, Vincenzo Costanzo, et al.
Microorganisms (2024) Vol. 12, Iss. 4, pp. 643-643
Open Access | Times Cited: 7

Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy
Yufei Xiang, Jialu Xu, Briana L. McGovern, et al.
Cell (2024)
Closed Access | Times Cited: 7

A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein
Vito Thijssen, Daniel L. Hurdiss, Oliver J. Debski-Antoniak, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 26
Open Access | Times Cited: 15

Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants
Lingyan Cui, Tingting Li, Wenhui Xue, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 900-900
Open Access | Times Cited: 6

Mechanistic insights into phosphoactivation of SLAC1 in guard cell signaling
Qin Li, Yanan Deng, Xiang-yun Zhang, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 29
Open Access | Times Cited: 6

SARS-CoV-2 Specific Nanobodies Neutralize Different Variants of Concern and Reduce Virus Load in the Brain of h-ACE2 Transgenic Mice
María F. Pavan, Marina Bok, Rafael Betanzos San Juan, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 185-185
Open Access | Times Cited: 5

Fast and accurate modeling and design of antibody-antigen complex using tFold
Fandi Wu, Yu Zhao, Jiaxiang Wu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5

Streamlining spatial omics data analysis with Pysodb
Senlin Lin, Fangyuan Zhao, Zihan Wu, et al.
Nature Protocols (2023) Vol. 19, Iss. 3, pp. 831-895
Closed Access | Times Cited: 12

Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes
Xixi Zhang, Zimu Li, Yanjun Zhang, et al.
Life Science Alliance (2023) Vol. 6, Iss. 9, pp. e202201796-e202201796
Open Access | Times Cited: 11

Revolutionizing SARS-CoV-2 omicron variant detection: Towards faster and more reliable methods
Dan Li, Cai Sun, Pengfei Zhuang, et al.
Talanta (2023) Vol. 266, pp. 124937-124937
Closed Access | Times Cited: 11

Application of Artificial Intelligence and Computational Biology in Protein Drug Development
Jiacheng Jiang, Wen Li, Weiran Huang, et al.
Pharmaceutical Fronts (2025)
Open Access

The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2
V. S. Aripov, Anna V. Zaykovskaya, Ludmila V. Mechetina, et al.
Antibodies (2025) Vol. 14, Iss. 1, pp. 23-23
Open Access

A bivalent spike-targeting nanobody with anti-sarbecovirus activity
Iris C. Swart, Oliver J. Debski-Antoniak, Aneta Zegar, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access

Optimization mechanism of laminated ceramic package structure on the regulation of semiconductor cooling performance
Shifeng Yan, Qian Zhao, Faxiang Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralization
Jing Yang, Sheng Lin, Zimin Chen, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011804-e1011804
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top